以岭药业：第三季度净利润同比增长1264.61%

Core Viewpoint - Yiling Pharmaceutical reported a decline in revenue for the first three quarters of 2025, while net profit saw significant growth, indicating a potential shift in profitability despite lower sales [1] Financial Performance - The company achieved an operating income of 5.868 billion yuan for the first three quarters, a year-on-year decrease of 7.82% [1] - Net profit attributable to shareholders reached 1 billion yuan, reflecting a year-on-year increase of 80.33% [1] - Basic earnings per share were reported at 0.5988 yuan [1] - In the third quarter, net profit attributable to shareholders was 332 million yuan, showing a remarkable year-on-year growth of 1264.61% [1]